How the Pharmaceutical Industry Can Navigate Supply Chain Disruptions and Gain Resiliency
Few shipments have higher stakes than those in the pharmaceutical industry. The distribution and safety of pharmaceutical products during transport have a direct impact on bottom lines AND medical outcomes: supply chain disruptions and excursions can not only result in millions of dollars in lost profit, but they can compromise people’s health and even lives.
This white paper features insights from Bobby Boehm, a subject matter expert in Global Supply Chain and Logistics and Cold Chain Management with over 30 years of experience as a pioneer in the Pharmaceutical Supply Chain space, about how the pharmaceutical industry can increase its resiliency, including key data on:
- The state of the pharmaceutical supply chain
- Challenges and risks associated with shipping pharmaceutical products
- Technological solutions for pharmaceutical supply chain professionals to consider
- Real-life case studies on how visibility keeps pharmaceutical shipments safe from disruptions
Please fill out the form to read the report!
Get your copy
Key Findings:
- Disruptions in the pharmaceutical supply chain directly affect firms' planning process around MOH (months on hand) coverage, and inventory needs are becoming increasingly difficult to predict.
- Pharmaceutical supply chains are particularly susceptible to certain challenges, including transportation delays, regulatory issues, temperature control events, and demand, supply, and safety stock imbalances.
- Best practices for pharmaceutical shipment location and monitoring are steadily moving away from reactive monitoring (such as passive data loggers) to proactive monitoring (such as real-time location and temperature tracking devices).
- Real-time visibility solutions and insights help keep pharmaceutical shipments safe and compliant while building supply chain resiliency.
